Concepedia

Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model

Anna Gustafsson, Tom Bäck, Jörgen Elgqvist, Lars Jacobsson, Ragnar Hultborn, Per Albertsson, Alfred Morgenstern, Frank Bruchertseifer, Holger Jensen, Sture Lindegren

Nuclear Medicine and Biology · 2011 · 47 citations · 33 references

DOI

Concepts

References

33

Cancer Statistics, 2008

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text

, , +16

Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of <sup>211</sup>At-MX35 F(ab′)<sub>2</sub>—A Phase I Study

Håkan Andersson, Elin Cederkrantz, Tom Bäck et al. · Journal of Nuclear Medicine · 2009 · 288 citations · Full text

, , +17

Production of Ac-225 from Th-229 for Targeted α Therapy

Christos Apostolidis, R. Molinet, Gert Rasmussen et al. · Analytical Chemistry · 2005 · 216 citations

, , +16

Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission

René H.M. Verheijen, Leon F.A.G. Massuger, Benedict B. Benigno et al. · Journal of Clinical Oncology · 2006 · 191 citations · Full text

, , +13

Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.

Tuomo Nikula, Michael R. McDevitt, Ronald D. Finn et al. · PubMed · 1999 · 177 citations

, , +17